Algorithm grades NASH from MRI scans in clinical study
August 16, 2018 NASH (*) has emerged as a concern for healthcare systems and a major opportunity for drug developers in recent years. The condition, a severe form of fatty liver disease, can arise as a comorbidity in people suffering from obesity and type 2 diabetes and can lead to cirrhosis. Drug developers including Intercept and … Read more